Consucon 60 MR mg Tablet ~ 1 Strip
Consucon 60 MR
is uniquely engineered for individuals managing Type 2 Diabetes Mellitus.
· Insulin Stimulation: It triggers the
release of insulin directly from the pancreatic beta cells by facilitating
smooth calcium ion transport across cell membranes.
· Hepatic Regulation:
It works downstream to lower excess glucose output from the liver.
The
special Modified Release
technology ensures the drug is absorbed gradually by the body, offering highly
effective, sustained blood sugar management with a reduced risk of sudden
hypoglycemic drops compared to older sulfonylureas.
· Type 2 Diabetes
Mellitus Management: Indicated for
maturity-onset diabetes in adults when specialized dietary changes, consistent
exercise, and weight loss alone are no longer enough to regulate HbA1c levels.
· Prevention of
Long-Term Complications: Consistently
controlling blood sugar with Consucon 60 MR safeguards the body against severe
diabetic complications such as progressive kidney damage, nerve problems, and
blindness.
· Sustained 24-Hour
Glycemic Control: The advanced
modified-release mechanism slowly dispenses the active compound, mirroring the
body's natural needs.
· Favorable Renal
Profile: Gliclazide is extensively metabolized
by the body, allowing it to be utilized safely by patients with
mild-to-moderate renal insufficiency without steep medication spikes.
· Protective
Hemobiological Properties: Offers potentially
useful hematological advantages, helping to minimize microthrombosis
(micro-clots) by partially reducing harmful platelet aggregation.
· Standard Adult Dose:
Typically 1 to 2 tablets (up to a maximum of 120 mg) taken once daily.
· Timing:
It is highly recommended to take the tablet at breakfast time
· How to Take:
Swallow the tablet whole with a glass of water.
· Active Ingredient:
Gliclazide BP 60 mg
· Quantity: 1 Strip (Contains 10 modified-release
tablets)
· Therapeutic Class: Sulfonylurea / Oral
Antidiabetic
· Suitability: Suitable for adults
with type 2 diabetes. (Contraindicated for Type 1
juvenile diabetes or diabetic ketoacidosis).
· Shelf Life: 36 months.
· Country of Origin:
Bangladesh
(Manufactured by Incepta Pharmaceuticals Ltd.).
· Storage:
Store below 30°C in a cool, dry place.
· Hypoglycemia Alert:
Skipping or delaying meals while taking this tablet can cause low blood sugar
(sweating, dizziness, tremors, or confusion).
· Pregnancy &
Lactation: This medication is strictly
contraindicated for pregnant women and nursing mothers.
Disclaimer:
This is a prescription-only maintenance medication.
Login Or Registerto submit your questions to seller
No none asked to seller yet